Noemi Lois is a Clinical Professor of Ophthalmology at Queens University and an Honorary Consultant Ophthalmologist and Vitreoretinal Surgeon at the Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
After finishing her training in Ophthalmology, Noemi completed clinical fellowships in Ocular Oncology at Wills Eye Hospital, Philadelphia, with Drs Jerry and Carol Shields; Medical Retina at Moorfields Eye Hospital, London, with Prof Alan Bird, and; Vitreoretinal Surgery at The Royal Liverpool University Hospital with Prof David Wong. Noemi then worked as full time Consultant Ophthalmic Surgeon for 13 years in Aberdeen before joining Queens University in 2013.
Noemi has published well over 100 articles in peer review journals [Scopus h-index (March 2021) = 41)], 13 book chapters and is editor of 3 textbooks, one on its second edition. Noemi is ad-hoc referee for numerous peer-review journals and funding bodies and has given numerous lectures as guest speaker at national and international meetings in China, India, Indonesia, Ireland, Italy, Malaysia, Singapore, South Africa, Switzerland, USA and the UK. Noemi is editorial board member for several journals including the Cochrane Eyes and Vision Group, and has participated, as a member of the Evidence Review Group, in over 10 Single Technology Appraisals for the UK National Institute of Health and Care Excellence (NICE) on new therapies for eye diseases.
Noemi has led multiple research projects throughout her career, being Chief Investigator of several multicentric trials for which she obtained competitive public funding, including FILMS (the Full-thickness macular hole and Internal Limiting Membrane peeling Study, funded by the Chief Scientist Office, Scotland), EMERALD (Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And New vesseLs in Diabetic retinopathy) and DIAMONDS (Diabetic Macular Oedema aNd Diode Subthreshold micropulse laser) funded by the Heallth Technology Assessment of the National Institute for Health Research in the UK, and co-lead of the EU H2020 funded RECOGNISED (Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia).”
Leave a Reply